Akèy › Maladi Crohn › Kalifòni › San Diego
Etid klinik pou Maladi Crohn nan San Diego, CA
15 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ap rekriteFaz 2
- Southern California Res. Ctr /ID# 280476, Coronado · 2 mi lwen
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- Clinical Applications Laboratories ( Site 5123), San Diego
- Southern California Research Center ( Site 5044), Coronado · 2 mi lwen
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Ap rekriteFaz 2
- Southern California Res. Ctr /ID# 265549, Coronado · 2 mi lwen
- UC San Diego Health System /ID# 265565, La Jolla · 11 mi lwen
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Medical Associates Research Group, Inc., San Diego
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2/3
- Medical Associates Research Group, Inc., San Diego
- Southern California Research Center, Coronado · 2 mi lwen
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Clinical Applications Laboratories Inc-Site Number: 8400056, San Diego
- Medical Associates Research Group-Site Number:8400063, San Diego
- Southern California GI & Liver Centers-Site Number: 8400062, Coronado · 2 mi lwen
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- Infinity Clinical Research, San Diego
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Ap rekriteFaz 4
- University of California San Diego Health (UCSD), La Jolla · 11 mi lwen
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Medical Associates Research Group, Inc., San Diego
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Ap rekrite
- UC San Diego Health, La Jolla · 11 mi lwen
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Ap rekriteFaz 3
- UCSD Medical Center, La Jolla · 11 mi lwen
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ap rekriteFaz 3
- Rady Children's Hospital - San Diego - PIN, San Diego
Precise Infliximab Exposure and Pharmacodynamic Control
Ap rekriteFaz 2/3
- Rady Children's Hospital San Diego, San Diego
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Ap rekriteFaz 3
- Rady Childrens Hospital San Diego - PIN, San Diego
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Ap rekriteEtid obsèvasyon
- University of California, San Diego, La Jolla · 11 mi lwen
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Tyler, TX17 etid
- Houston, TX17 etid
- Orlando, FL17 etid
- Atlanta, GA17 etid
- San Antonio, TX15 etid
- Los Angeles, CA15 etid
- Colorado Springs, CO13 etid
Lòt etid nan San Diego
- Kansè Poumon ki pa ti selil48 etid
- Kansè nan tete41 etid
- Kansè (tout kalite)32 etid
- Kansè pwostat31 etid
- Kansè Metastatik30 etid
- Kansè kolorektal25 etid
- Kansè ovè24 etid
- Kansè pankreyas24 etid
- Kansè poumon23 etid
- Obèsite23 etid
- Ensifizyans kadyak23 etid
- Depresyon21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.